Surface-confined CRISPR-Cas12a biosensor with metal-enhanced fluorescence for rapid and ultrasensitive detection of SARS-CoV-2 nucleocapsid protein.

Publication date: Aug 15, 2026

CRISPR-Cas12a integrated with nanomaterials has formulated powerful biosensors for viral protein detection, addressing the urgent need for point-of-care diagnostics. However, existing platforms are hindered by either multi-step separation procedures or insufficient signal amplification, limiting their sensitivity and practicality. Here, we report a one-pot “on-off” biosensor that combines metal-enhanced fluorescence (MEF) and nanoscale spatial confinement by co-localizing both reporter substrates and the CRISPR-Cas12a system on gold-silica core-shell nanoparticles (Au@SiO NPs), enabling rapid and ultrasensitive protein detection. Using SARS-CoV-2 nucleocapsid (N) protein as a model analyte, Au@SiO NPs are co-functionalized with (i) ssDNA activators blocked by N protein-specific aptamers, (ii) light-up hairpin DNA (DAP) complexed with auramine O (AO) as reporters, and (iii) short polyethylene glycol (PEG) spacers to mitigate steric hindrance. The nanoplatform displays an ultrabright “on-state” fluorescence, with an intensity >860-fold higher than that of free AO, enabled by the interaction with DAP and optimized fluorophore-metal spacing (∼20 nm). Upon target binding, aptamer displacement exposes the activator to locally initiate Cas12a trans-cleavage, disrupting proximal DAP structure and its interaction with AO, thereby producing a distinct “off-state” signal. Within the linear detection range, the system demonstrates up to ∼85% signal reduction relative to the initial signal and a signal-to-noise ratio (SNR) of 83. 89, corresponding to a ∼2. 5-fold higher SNR than the solution-phase system. The platform attains a limit of detection at 67. 2 fg/mL within 30 min, with excellent sensitivity, selectivity, stability, and recovery in bronchoalveolar lavage fluid. By combining MEF-driven signal amplification with surface-confined CRISPR-Cas12a trans-cleavage, this platform establishes an efficient strategy for sensitive N protein detection.

Concepts Keywords
Bioelectron Aptamers, Nucleotide
Short Aptamers, Nucleotide
Spacers Biosensing Techniques
Viral Core-shell nanoparticles
Coronavirus Infections
Coronavirus Nucleocapsid Proteins
Coronavirus Nucleocapsid Proteins
COVID-19
CRISPR-Associated Proteins
CRISPR-Associated Proteins
CRISPR-Cas Systems
Fluorescence
Gold
Gold
Humans
Limit of Detection
Localized CRISPR-Cas12a
Metal Nanoparticles
Metal-enhanced fluorescence
nucleocapsid phosphoprotein, SARS-CoV-2
Nucleocapsid Proteins
Nucleocapsid Proteins
Phosphoproteins
Phosphoproteins
Pneumonia, Viral
Protein detection
SARS-CoV-2
Silicon Dioxide
Silicon Dioxide

Semantics

Type Source Name
pathway REACTOME Signal amplification
drug DRUGBANK Gold
drug DRUGBANK Silicon dioxide
disease MESH NPs
drug DRUGBANK Amifampridine
drug DRUGBANK Polyethylene glycol
disease MESH Coronavirus Infections
disease MESH COVID-19
disease MESH Cas
disease MESH Pneumonia Viral

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *